Sökning: L773:1435 4373 OR L773:0934 9723 >
In vitro activity o...
-
Germel, C.Department of Laboratory Medicine, Clinical Microbiology, Örebro University Hospital, Örebro, Sweden
(författare)
In vitro activity of beta-lactam antibiotics to community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)
- Artikel/kapitelEngelska2012
Förlag, utgivningsår, omfång ...
-
2011-07-09
-
New York, USA :Springer,2012
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:oru-25343
-
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-25343URI
-
https://doi.org/10.1007/s10096-011-1333-8DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Community-associated (CA) MRSA often display low MIC values against oxacillin. The in vitro activity of various beta-lactam antibiotics against heterogeneous CA-MRSA (n = 98) isolated in a low endemic area was determined by Etest, and Mueller-Hinton agar (MUHAP) was compared with Mueller-Hinton agar supplemented with 2% NaCl (MUHSP). In general, the CA-MRSA isolates showed higher MIC values for the various beta-lactam antibiotics on MUHSP compared with MUHAP. MIC values for oxacillin ranged from 1 to >256 mg/L on MUHSP. Cephalothin, representing the first generation of cephalosporins, showed MICs from 0.75 to 96 mg/L and the MIC(50) and MIC(90) for cefuroxime, cefotaxime and cefepime, representing the second, third and fourth generations, respectively, were rather high. However, the MIC(50) and MIC(90) for ceftobiprole (fifth generation) were 1.5 and 2 mg/L, respectively, on MUHSP. The MIC(50) and MIC(90) for imipenem were 0.75 and 2 mg/L, respectively, on MUHSP. Only 3/98 (3%) CA-MRSA isolates showed a MIC >4 mg/L. Consequently, low MIC values for imipenem, lower than those of the newly developed fifth generation cephalosporins, were found among CA-MRSA. These findings may be considered for further studies including clinical trials in order to evaluate carbapenems as a potential treatment option for infections caused by CA-MRSA.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Haag, A.Department of Laboratory Medicine, Clinical Microbiology, Örebro University Hospital, Örebro, Sweden
(författare)
-
Söderquist, Bo,1955-Department of Laboratory Medicine, Clinical Microbiology, Örebro University Hospital, Örebro, Sweden(Swepub:oru)bost
(författare)
-
Department of Laboratory Medicine, Clinical Microbiology, Örebro University Hospital, Örebro, Sweden
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:European Journal of Clinical Microbiology and Infectious DiseasesNew York, USA : Springer31:4, s. 475-4800934-97231435-4373
Internetlänk
Hitta via bibliotek
Till lärosätets databas